Caina Technology Co

Caina Technology Co Capital Expenditures

The Capital Expenditures (CapEx) of Caina Technology Co (301122.SZ) as of Oct 30, 2026 is -92.72 M CNY. In the previous year, Capital Expenditures (CapEx) was -101.85 M CNY — a change of -8.96% (higher).

Capital Expenditures

-92.72 MCNY

YoY

-8.96%

Last updated:

Capital Expenditures (CapEx) of Caina Technology Co is 2025 -92.72 M CNY. Capital Expenditures (CapEx) of Caina Technology Co was 2024 -101.85 M CNY. It decreases by -8.96% higher compared to the previous year.

The Caina Technology Co Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-19.83 M CNY
Jan 1, 2019
-48.82 M CNY
Jan 1, 2020
-72.23 M CNY
Jan 1, 2021
-97.15 M CNY
Jan 1, 2022
-164.83 M CNY
Jan 1, 2023
-197.82 M CNY
Jan 1, 2024
-101.85 M CNY
Jan 1, 2025
-92.72 M CNY
The Caina Technology Co Capital Expenditures history
YEARCapital ExpendituresYoY
-92.72 MCNY-8.96%
-101.85 MCNY-48.52%
-197.82 MCNY+20.01%
-164.83 MCNY+69.66%
-97.15 MCNY+34.50%
-72.23 MCNY+47.95%
-48.82 MCNY+146.19%
-19.83 MCNY-41.41%
-33.85 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Capital Expenditures (CapEx) of Caina Technology Co is -92.72 M CNY in 2025.

Capital Expenditures (CapEx) of Caina Technology Co changed from -101.85 M CNY to -92.72 M CNY, representing a -8.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Caina Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Caina Technology Co

All Key Metrics — Caina Technology Co